202 related articles for article (PubMed ID: 3119941)
1. Adrenoleukodystrophy: biochemical procedures in diagnosis, prevention and treatment.
Watkins PA; Naidu S; Moser HW
J Inherit Metab Dis; 1987; 10 Suppl 1():46-53. PubMed ID: 3119941
[TBL] [Abstract][Full Text] [Related]
2. Adrenoleukodystrophy: from bedside to molecular biology.
Moser HW
J Child Neurol; 1987 Apr; 2(2):140-50. PubMed ID: 3598142
[TBL] [Abstract][Full Text] [Related]
3. Detection of adrenoleukodystrophy by increased C26:0 fatty acid levels in leukocytes.
Molzer B; Bernheimer H; Heller R; Toifl K; Vetterlein M
Clin Chim Acta; 1982 Nov; 125(3):299-305. PubMed ID: 7172439
[TBL] [Abstract][Full Text] [Related]
4. Adrenoleukodystrophy: survey of 303 cases: biochemistry, diagnosis, and therapy.
Moser HW; Moser AE; Singh I; O'Neill BP
Ann Neurol; 1984 Dec; 16(6):628-41. PubMed ID: 6524872
[TBL] [Abstract][Full Text] [Related]
5. The design of a diet restricted in saturated very long-chain fatty acids: therapeutic application in adrenoleukodystrophy.
Van Duyn MA; Moser AE; Brown FR; Sacktor N; Liu A; Moser HW
Am J Clin Nutr; 1984 Aug; 40(2):277-84. PubMed ID: 6465061
[TBL] [Abstract][Full Text] [Related]
6. Linkage of adrenoleukodystrophy to a polymorphic DNA probe.
Aubourg PR; Sack GH; Meyers DA; Lease JJ; Moser HW
Ann Neurol; 1987 Apr; 21(4):349-52. PubMed ID: 2883927
[TBL] [Abstract][Full Text] [Related]
7. Adrenoleukodystrophy: dietary oleic acid lowers hexacosanoate levels.
Rizzo WB; Phillips MW; Dammann AL; Leshner RT; Jennings SS; Avigan J; Proud VK
Ann Neurol; 1987 Mar; 21(3):232-9. PubMed ID: 3037987
[TBL] [Abstract][Full Text] [Related]
8. A new dietary therapy for adrenoleukodystrophy: biochemical and preliminary clinical results in 36 patients.
Moser AB; Borel J; Odone A; Naidu S; Cornblath D; Sanders DB; Moser HW
Ann Neurol; 1987 Mar; 21(3):240-9. PubMed ID: 2440378
[TBL] [Abstract][Full Text] [Related]
9. Dietary erucic acid therapy for X-linked adrenoleukodystrophy.
Rizzo WB; Leshner RT; Odone A; Dammann AL; Craft DA; Jensen ME; Jennings SS; Davis S; Jaitly R; Sgro JA
Neurology; 1989 Nov; 39(11):1415-22. PubMed ID: 2682348
[TBL] [Abstract][Full Text] [Related]
10. Adrenoleukodystrophy: effects of dietary restriction of very long chain fatty acids and of administration of carnitine and clofibrate on clinical status and plasma fatty acids.
Brown FR; Van Duyn MA; Moser AB; Schulman JD; Rizzo WB; Snyder RD; Murphy JV; Kamoshita S; Migeon CJ; Moser HW
Johns Hopkins Med J; 1982 Oct; 151(4):164-72. PubMed ID: 7120720
[No Abstract] [Full Text] [Related]
11. Adrenoleukodystrophy: diagnosis and carrier detection by determination of long-chain fatty acids in cultured fibroblasts.
Tönshoff B; Lehnert W; Ropers HH
Clin Genet; 1982 Jul; 22(1):25-9. PubMed ID: 7172473
[TBL] [Abstract][Full Text] [Related]
12. First trimester prenatal diagnosis of adrenoleukodystrophy by determination of very long chain fatty acid levels and by linkage analysis to a DNA probe.
Boué J; Oberle I; Heilig R; Mandel JL; Moser A; Moser H; Larsen JW; Dumez Y; Boué A
Hum Genet; 1985; 69(3):272-4. PubMed ID: 3856557
[TBL] [Abstract][Full Text] [Related]
13. Adrenoleukodystrophy: increased plasma content of saturated very long chain fatty acids.
Moser HW; Moser AB; Frayer KK; Chen W; Schulman JD; O'Neill BP; Kishimoto Y
Neurology; 1981 Oct; 31(10):1241-9. PubMed ID: 7202134
[TBL] [Abstract][Full Text] [Related]
14. [Adrenoleukodystrophy: significance for genetic counseling of the determination of very long-chain fatty acids and of molecular biology].
Mathieu M; Aubourg P; Guidoux S; Epelbaum S; Benhamou P; Berquin P; Boudailliez B; Piussan C
Ann Pediatr (Paris); 1990 Mar; 37(3):157-61. PubMed ID: 2350140
[TBL] [Abstract][Full Text] [Related]
15. Profiles of very-long-chain fatty acids in plasma, fibroblasts, and blood cells in Zellweger syndrome, X-linked adrenoleukodystrophy, and rhizomelic chondrodysplasia punctata.
Schutgens RB; Bouman IW; Nijenhuis AA; Wanders RJ; Frumau ME
Clin Chem; 1993 Aug; 39(8):1632-7. PubMed ID: 8353949
[TBL] [Abstract][Full Text] [Related]
16. Identification of female carriers of adrenoleukodystrophy.
Moser HW; Moser AE; Trojak JE; Supplee SW
J Pediatr; 1983 Jul; 103(1):54-9. PubMed ID: 6864396
[TBL] [Abstract][Full Text] [Related]
17. [Familial adrenoleukodystrophy].
Le Fur JM; Le Meur F; Parent P; Toudic L; Castel Y
J Genet Hum; 1985 Dec; 33(5):427-34. PubMed ID: 4093772
[TBL] [Abstract][Full Text] [Related]
18. [Apropos of a familial case of adrenoleukodystrophy related to X chromosome diagnosed prenatally].
Parent P; Le Meur F; Alix D; Le Fur JM; Toudic L; Castel Y
Pediatrie; 1987; 42(4):297-301. PubMed ID: 3671029
[TBL] [Abstract][Full Text] [Related]
19. Carrier detection in X-linked adrenoleukodystrophy by determination of very long chain fatty acid levels and by linkage analysis.
Notarangelo LD; Parolini O; Baiguini G; Buzi F; Paterlini C; Perini A; Rimoldi M; Tiberti S; Uziel G; Notarangelo L
Eur J Pediatr; 1992 Oct; 151(10):761-3. PubMed ID: 1425799
[TBL] [Abstract][Full Text] [Related]
20. [Examination of very long chain fatty acids in diagnosis of x-linked adrenoleukodystrophy].
Stradomska TJ; Tylki-Szymańska A
Pediatr Pol; 1996 Mar; 71(3):197-201. PubMed ID: 8966090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
